These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 17488144)

  • 1. Scleroderma lung: pathogenesis, evaluation and current therapy.
    van Laar JM; Stolk J; Tyndall A
    Drugs; 2007; 67(7):985-96. PubMed ID: 17488144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment Algorithms for Systemic Sclerosis According to Experts.
    Fernández-Codina A; Walker KM; Pope JE;
    Arthritis Rheumatol; 2018 Nov; 70(11):1820-1828. PubMed ID: 29781586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclophosphamide versus placebo in scleroderma lung disease.
    Tashkin DP; Elashoff R; Clements PJ; Goldin J; Roth MD; Furst DE; Arriola E; Silver R; Strange C; Bolster M; Seibold JR; Riley DJ; Hsu VM; Varga J; Schraufnagel DE; Theodore A; Simms R; Wise R; Wigley F; White B; Steen V; Read C; Mayes M; Parsley E; Mubarak K; Connolly MK; Golden J; Olman M; Fessler B; Rothfield N; Metersky M;
    N Engl J Med; 2006 Jun; 354(25):2655-66. PubMed ID: 16790698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of interstitial lung disease in systemic sclerosis: lessons from SLS and FAST.
    Fathi N; Furst DE; Clements PJ
    Curr Rheumatol Rep; 2007 May; 9(2):144-50. PubMed ID: 17502045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclophosphamide versus mycophenolate mofetil in scleroderma interstitial lung disease (SSc-ILD) as induction therapy: a single-centre, retrospective analysis.
    Shenoy PD; Bavaliya M; Sashidharan S; Nalianda K; Sreenath S
    Arthritis Res Ther; 2016 Jun; 18(1):123. PubMed ID: 27255492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic scleroderma-related interstitial pneumonia associated with borderline pulmonary arterial hypertension.
    Sugino K; Kabuki T; Shibuya K; Homma S
    BMJ Case Rep; 2018 May; 2018():. PubMed ID: 29804068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of cyclophosphamide on pulmonary function in patients with scleroderma and interstitial lung disease: a systematic review and meta-analysis of randomized controlled trials and observational prospective cohort studies.
    Nannini C; West CP; Erwin PJ; Matteson EL
    Arthritis Res Ther; 2008; 10(5):R124. PubMed ID: 18937831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial.
    Tashkin DP; Roth MD; Clements PJ; Furst DE; Khanna D; Kleerup EC; Goldin J; Arriola E; Volkmann ER; Kafaja S; Silver R; Steen V; Strange C; Wise R; Wigley F; Mayes M; Riley DJ; Hussain S; Assassi S; Hsu VM; Patel B; Phillips K; Martinez F; Golden J; Connolly MK; Varga J; Dematte J; Hinchcliff ME; Fischer A; Swigris J; Meehan R; Theodore A; Simms R; Volkov S; Schraufnagel DE; Scholand MB; Frech T; Molitor JA; Highland K; Read CA; Fritzler MJ; Kim GHJ; Tseng CH; Elashoff RM;
    Lancet Respir Med; 2016 Sep; 4(9):708-719. PubMed ID: 27469583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bronchoalveolar lavage and response to cyclophosphamide in scleroderma interstitial lung disease.
    Strange C; Bolster MB; Roth MD; Silver RM; Theodore A; Goldin J; Clements P; Chung J; Elashoff RM; Suh R; Smith EA; Furst DE; Tashkin DP;
    Am J Respir Crit Care Med; 2008 Jan; 177(1):91-8. PubMed ID: 17901414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interstitial lung disease in systemic sclerosis: pathophysiology, current and new advances in therapy.
    Jain S; Shahane A; Derk CT
    Inflamm Allergy Drug Targets; 2012 Aug; 11(4):266-77. PubMed ID: 22506881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current drug therapy for scleroderma and secondary Raynaud's phenomenon: evidence-based review.
    Henness S; Wigley FM
    Curr Opin Rheumatol; 2007 Nov; 19(6):611-8. PubMed ID: 17917543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Management of patients with systemic sclerosis].
    Wiesik-Szewczyk E; Olesińska M
    Pol Merkur Lekarski; 2010 May; 28(167):421-3. PubMed ID: 20568411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug treatment of scleroderma.
    Leighton C
    Drugs; 2001; 61(3):419-27. PubMed ID: 11293650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclophosphamide in scleroderma lung disease.
    Andreu JL; Silva L
    N Engl J Med; 2006 Sep; 355(11):1173; author reply 1174. PubMed ID: 16977700
    [No Abstract]   [Full Text] [Related]  

  • 15. Systemic Sclerosis and Pulmonary Disease.
    Ngo K
    Adv Exp Med Biol; 2021; 1303():173-182. PubMed ID: 33788193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Scleroderma lung: pathogenesis, evaluation, and current therapy.
    Co HT; Block JA; Sequeira W
    Am J Ther; 2000 Sep; 7(5):321-4. PubMed ID: 11317180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunosuppressive treatment of the pulmonary manifestations of progressive systemic sclerosis.
    Vallance DK; Lynch JP; McCune WJ
    Curr Opin Rheumatol; 1995 May; 7(3):174-82. PubMed ID: 7612408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclophosphamide in scleroderma lung disease.
    Kuschner WG
    N Engl J Med; 2006 Sep; 355(11):1173; author reply 1174. PubMed ID: 16971726
    [No Abstract]   [Full Text] [Related]  

  • 19. [Cardiac and pulmonary involvement in scleroderma].
    Launay D; Hachulla E
    Rev Prat; 2002 Nov; 52(17):1901-7. PubMed ID: 12532867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel therapeutic approach to the treatment of scleroderma-associated pulmonary complications: safety and efficacy of combination therapy with imatinib and cyclophosphamide.
    Sabnani I; Zucker MJ; Rosenstein ED; Baran DA; Arroyo LH; Tsang P; Zubair M; Rivera V
    Rheumatology (Oxford); 2009 Jan; 48(1):49-52. PubMed ID: 18815156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.